Leiomyomatosis peritonealis disseminata. Two case reports

AIM: To study the action of quercetin (Que) on inhibiting platelet aggregation. METHODS: Active oxygen free radicals produced by xanthine/xanthine oxidase (Xan/XO) reaction was used, platelet aggregation was determined by the turbidimetric method, and the Xan/XO oxyradicals generating reaction by luminol-dependent chemiluminescence (Che) method. RESULTS: Active oxygen free radicals enhanced the platelet aggregation induced by ADP 1.6 mumol.L-1. The rate of maximal aggregation increased from 29%-38% for ADP to 59%-70% for ADP + Xan/XO. The enhancement was abolished by the treatment of platelet-rich plasma (PRP) with Que 650 mumol.L-1 or hydrocortisone (Hyd) 900 mg.L-1. Both Que and Hyd scavenged the active oxyradicals in vitro. The Che was decreased by 75.7% (Que 4 mumol.L-1) and 79.0% (Hyd 900 mg.L-1) as compared with control. CONCLUSION: Active oxygen free radicals participated in the platelet aggregation, and scavenging oxyradicals by Que was one of mechanisms of inhibiting platelet aggregation.     

新取代苯基荧光酮试剂的合成及其性质的研究Ⅱ．新型取代苯基荧光酮与金属离子显色反应的研究

研究了３，５－二溴－４－氨基苯基荧光酮、３，５－二溴－４－偶氮变色酸等８种苯基荧光酮在酸性介质中与高价金属离子Ｚｒ（Ⅳ）、Ｍｏ（Ⅵ）、Ｗ（Ⅵ）、Ａｌ（Ⅲ）、Ｇａ（Ⅲ）等的显色反应。３，５－位二溴取代的试剂的灵敏度高于未取代的灵敏度，摩尔吸光系数绝大多数在１０５Ｌ·ｍｏｌ－１·ｃｍ－１以上。     

钛容器的特点

根据钛材的化学、物理、力学和工艺性能介绍了钛容器在设计、制造、检验和应用方面的特点。     

热流法计算高温炉内辐射传热

高温炉内的辐射传热是工业生产中常遇到的问题。过去，人们在应用热流法计算辐射传热时遇到了一定的困难，使计算结果与实际有一定的偏差。本文运用文献［１］中给出的新热流数学模型，开发出由新热流方程与能量方程相耦合的计算机程序，其中的比热流参数由线加热热源情况下计算得到。用该程序计算了实验室用马弗炉内的温度场，并且用热电偶实测了炉内的一些温度值，理论计算与实测值符合很好。     

Analysis of a resonant-cavity enhanced GaAs/AlGaAs MSMphotodetector

The authors have developed a 2-D device simulator for heterostructure metal-semiconductor-metal (MSM) photodetectors. They have incorporated a model of multilayer optics into the simulator and used it to analyze the temporal response of a resonant-cavity enhanced heterostructure with a confining buffer layer and a distributed Bragg reflector (DBR). The authors show that through fine tuning the layer thicknesses, optical resonance enhancement of the light absorption can be obtained     

Cost Effective VLSI Architectures for Full-Search Block-Matching Motion Estimation Algorithm

In this paper, we present efficient VLSI architectures for full-search block-matching motion estimation (BMME) algorithm. Given a search range, we partition it into sub-search arrays called tiles. By fully exploiting data dependency within a tile, efficient VLSI architectures can be obtained. Using the proposed VLSI architectures, all the block-matchings in a tile can be processed in parallel. All the tiles within a search range can be processed serially or concurrently depending on various requirements. With the consideration of processing speed, hardware cost, and I/O bandwidth, the optimal tile size for a specific video application is analyzed. By partitioning a search range into tiles with appropriate size, flexible VLSI designs with different throughput can be obtained. In this way, cost effective VLSI designs for a wide range of video applications, from H.261 to HDTV, can be achieved.     

TNT-RDX混合废水处理的实验研究——生物-吸附法

介绍了在２５￣３５℃的温度下，用厌氧－兼氧－水生生物－吸附组合工艺处理ＴＮＴ和ＲＤＸ混合废水的方法，进行了日处理量为６０￣９００Ｌ的实验室放大实验。当ＴＮＴ和ＲＤＸ混合废水总浓度为４￣１２ｍｇ／Ｌ时，经过该工艺处理后可达到国家排放标准。其中厌氧－兼氧能去除废水中８０％以上的ＴＮＴ和ＲＤＸ，水生生物（水葫芦）对ＴＮＴ及ＲＤＸ也有一定的降解效果，最后用活性炭吸附可以实现深度处理。     

ACAT inhibitors derived from hetero-Diels-Alder cycloadducts of thioaldehydes

Acyl-CoA:cholesterol acyltransferase (ACAT) is the enzyme largely responsible for intracellular cholesterol esterification. A systemic inhibitor of ACAT is believed to be able to slow or even reverse the atherosclerotic process. Towards that goal, a series of cyclic sulfides, derived from the hetero-Diels-Alder reaction of thioaldehydes with 1,3-dienes, and bearing carboxamide substituents, were prepared and evaluated for in vitro (in several tissues and species) and ex vivo ACAT inhibition. Minor changes in subsequent structure were found to have a significant effect in optimization of the biological activity of this series of compounds.     

Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2

Prostaglandin A2 (PGA2) potently inhibits cell proliferation and suppresses tumor growth in vivo, but little is known regarding the molecular mechanisms mediating these effects. Here we demonstrate that treatment of breast carcinoma MCF-7 cells with PGA2 leads to G1 arrest associated with a dramatic decrease in the levels of cyclin D1 and cyclin-dependent kinase 4 (cdk4) and accompanied by an increase in the expression of p21. We further show that these effects occur independent of cellular p53 status. The decline in cyclin D and cdk4 protein levels is correlated with loss in cdk4 kinase activity, cdk2 activity is also significantly inhibited in PGA2-treated cells, an effect closely associated with the upregulation of p21. Immunoprecipitation experiments verified that p21 was indeed complexed with cdk2 in PGA2-treated cells. Additional experiments with synchronized MCF-7 cultures stimulated with serum revealed that treatment with PGA2 prevents the progression of cells from G1 to S. Accordingly, the kinase activity associated with cdk4, cyclin E, and cdk2 immunocomplexes, which normally increases following serum addition, was unchanged in PGA2-treated cells. Furthermore, the retinoblastoma protein (Rb), a substrate of cdk4 and cdk2 whose phosphorylation is necessary for cell cycle progression, remains underphosphorylated in PGA2-treated serum-stimulated cells. These findings indicate that PGA2 exerts its growth-inhibitory effects through modulation of the expression and/or activity of several key G1 regulatory proteins. Our results highlight the chemotherapeutic potential of PGA2, particularly for suppressing growth of tumors lacking p53 function.